Sheng, Xiujie <br/><br/>
Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer.  [electronic resource] 

 -  Oncology reports  Jul 2014 
 - 277-85 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1791-2431 
<br/><br/><label>Standard No.: </label>10.3892/or.2014.3208  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Azacitidine--analogs & derivatives<br/>Carcinoma, Ovarian Epithelial<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>DNA Methylation--drug effects<br/>Decitabine<br/>Epigenesis, Genetic<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Genes, Tumor Suppressor<br/>Humans<br/>Neoplasms, Glandular and Epithelial--genetics<br/>Ovarian Neoplasms--genetics<br/>Ovary--metabolism<br/>Promoter Regions, Genetic<br/>RNA, Long Noncoding--genetics<br/>Tumor Suppressor Protein p53--metabolism